DEA Reschedules FDA-Approved Marijuana Products and State-Licensed Medical Marijuana to Schedule III
EXECUTIVE SUMMARY - On April 22, 2026, Acting Attorney General Todd Blanche signed a final order transferring U.S. Food and Drug ...
Bank capacity is positioned to support origination growth in 2026. Aggregate indicators across balance-sheet constraints, ...
On April 16, 2026, the Federal Trade Commission (FTC) published an advance notice of proposed rulemaking (ANPRM) to address potential unfair ...
To prove a claim of work-related discrimination or retaliation, an employee must prove that he or she suffered an “adverse employment action.” ...
The role of Trustee is multifaceted. A Trustee acts as an administrative professional, tax preparer, asset manager, trusted family advisor, ...
As the ongoing turmoil in the Persian Gulf has demonstrated, crises are, unfortunately, a recurring part of the business landscape.
Recent Federal Circuit decision draws a meaningful distinction between patents that claim a broad genus as the invention itself and those that claim ...
As we previously reported here in Cabinet News & Views, the Federal Reserve, the OCC, and the FDIC reproposed the Basel III Endgame package ...
AI notetakers are everywhere. The conversation about whether and how to use them – from consent obligations and confidentiality risks to ...
The Illinois Genetic Information Privacy Act, (GIPA) has become one of the plaintiff class action bar’s favorite causes of action. GIPA regulates ...
In our 2025 outlook, we identified power availability and interconnection delays as emerging constraints on data center ...
As discussed previously (“New FDA Guidance Allows Biosimilar Applicants to Use Data From Outside the U.S. To Accelerate Their Approval in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results